‘Don’t panic’: On-demand dosing and overseas suppliers are options during PrEP shortage
Supplies of PrEP will be limited under at least November, health officials says.
A shortage of tenofovir disoproxil–emtricitabine tablets for HIV pre-exposure prophylaxis will mean careful planning with patients over upcoming months, the TGA says.
Various brands of pre-exposure prophylaxis (PrEP) drugs have been in shortage since May 2024, which health officials have blamed on manufacturing issues.
But problems have worsened in the last few months and NSW Health is now warning that supply is unlikely to return to normal until at least November.
GP and sexual health physician Associate Professor Jason Ong says patients at the Melbourne Sexual Health Centre, where he works, are struggling to find pharmacies with PrEP in stock.
